Evidence map›Paper›PMID 24776686›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Tanya L Daigle, Mark J Ferris, Raul R Gainetdinov, Tatyana D Sotnikova, Nikhil M Urs, Sara R Jones, Marc G Caron

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. The Signaling and Pharmacology of the Dopamine D1 Receptor.Frontiers in cellular neuroscience · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. New Concepts in Dopamine DBiological psychiatry · 2017
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Tanya L Daigle1] Department of Cell Biology, Duke University Medical Center, Durham, NC, USA [2] Department of Brain and Cognitive Sciences, McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Mark J FerrisDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Raul R Gainetdinov1] Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy [2] Skolkovo Institute of Science and Technology, Skolkovo, Moscow Region, Russia [3] Faculty of Biology and Soil Science, St Petersburg State University, St Petersburg, Russia.
Tatyana D SotnikovaDepartment of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy.
Nikhil M UrsDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Sara R JonesDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Marc G CaronDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.
Duke University Hospital · USItalian Institute of Technology · ITWake Forest University · USDuke Medical Center · US

Funding

TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOWLETT, ALLYN C · 1991 to 2019
$30.8M
Screening CoreU19MH082441 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, MARC G., CARON, MARC G. · 2007 to 2016
$15.2M
Role of Kappa Opioid Receptors in Maladaptive Catecholamine Responses to Stress and Alcohol ExposureU01AA014091 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Katherine Mercedes Holleran, SARA RAULERSON JONES · 2003 to 2026
$7.7M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR37MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2011 to 2020
$6.4M
Science PlanP30DA029925 · NIDA · DUKE UNIVERSITY · PI CARON, MARC G. · 2010 to 2018
$6.2M
Translational Studies on Early-life Stress and Vulnerability to Alcohol AddictionP01AA021099 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WEINER, JEFFREY L. · 2012 to 2016
$2.8M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR01MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2005 to 2009
$2.1M
Dopamine Transporter Changes Following Cocaine Self-AdministrationR01DA021325 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA RAULERSON · 2007 to 2011
$1.4M
Methylphenidate, Serotonin and Dopamine InteractionsR01DA030161 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA RAULERSON · 2010 to 2014
$1.4M
nAChR sensitivity and individual differences in drug abuse vulnerabilityR00DA031791 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 2015 to 2017
$743k
Ethanol, NMDA Receptor and Dopamine InteractionsR21AA013900 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA R · 2004 to 2006
$400k
nAChR Sensitivity and Individual Differences in Drug Abuse VulnerabilityK99DA031791 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 2012 to 2013
$188k
NIAAA NIH HHS P01 AA021099NIAAA NIH HHS R21 AA013900NIAAA NIH HHS U01 AA014091NIDA NIH HHS DA024095NIDA NIH HHS DA030026NIDA NIH HHS DA030161NIDA NIH HHS DA031791NIDA NIH HHS P30-DA029925NIDA NIH HHS P50 DA006634NIDA NIH HHS R01 DA021325NIDA NIH HHS R01 DA030161NIMH NIH HHS MH073853NIMH NIH HHS R37 MH073853NIMH NIH HHS U19 MH082441NIMH NIH HHS U19-MH082441
6 · The paper itself

Abstract

GRK2 is a G protein-coupled receptor kinase (GRK) that is broadly expressed and is known to regulate diverse types of receptors. GRK2 null animals exhibit embryonic lethality due to a severe developmental heart defect, which has precluded the study of this kinase in the adult brain. To elucidate the specific role of GRK2 in the brain dopamine (DA) system, we used a conditional gene knockout approach to selectively delete GRK2 in DA D1 receptor (D1R)-, DA D2 receptor (D2R)-, adenosine 2A receptor (A2AR)-, or DA transporter (DAT)-expressing neurons. Here we show that select GRK2-deficient mice display hyperactivity, hyposensitivity, or hypersensitivity to the psychomotor effects of cocaine, altered striatal signaling, and DA release and uptake. Mice with GRK2 deficiency in D2R-expressing neurons also exhibited increased D2 autoreceptor activity. These findings reveal a cell-type-specific role for GRK2 in the regulation of normal motor behavior, sensitivity to psychostimulants, dopamine neurotransmission, and D2 autoreceptor function.

Indexed as

Synaptic TransmissionAnimalsBrainCentral Nervous System StimulantsCocaineConditioning, PsychologicalDopamineDopamine Plasma Membrane Transport ProteinsG-Protein-Coupled Receptor Kinase 2Mice, KnockoutMotor ActivityNeuronsReceptor, Adenosine A2AReceptors, Dopamine D1Receptors, Dopamine D2Space PerceptionCentral Nervous System StimulantsCocaineDopamineDopamine Plasma Membrane Transport ProteinsG-Protein-Coupled Receptor Kinase 2GRK2 protein, mouseReceptor, Adenosine A2AReceptors, Dopamine D1Receptors, Dopamine D2

Identifiers

PMID24776686
PMCPMC4138757
OpenAlexW2033903540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.